Non-esterified fatty acids and risk of peripheral artery disease in older adults: The cardiovascular health study.

[1]  A. Stewart,et al.  The Interplay between Non-Esterified Fatty Acids and Plasma Zinc and Its Influence on Thrombotic Risk in Obesity and Type 2 Diabetes , 2021, International journal of molecular sciences.

[2]  A. Lichtenstein,et al.  Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort , 2021, Journal of the American Heart Association.

[3]  A. Newman,et al.  Non‐Esterified Fatty Acids and Risks of Frailty, Disability, and Mobility Limitation in Older Adults: The Cardiovascular Health Study , 2020, Journal of the American Geriatrics Society.

[4]  Wenjie Kang,et al.  Exploring the effects of free fatty acids in rat serum on the coronary atherosclerotic plaque formation by the CT projection measurement results of compression sensor , 2020, Measurement.

[5]  Amélie I S Sobczak,et al.  Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes , 2019, Nutrients.

[6]  Khendi White Solaru.  Peripheral Artery Disease and African Americans: Review of the Literature , 2019, Current Cardiovascular Risk Reports.

[7]  M. Zdravkovska,et al.  Cigarette Smoking and Oxidative Stress in Patients with Coronary Artery Disease , 2016, Open access Macedonian journal of medical sciences.

[8]  L. Kuller,et al.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study , 2016, Circulation.

[9]  Q. Niu,et al.  Association of Serum Free Fatty Acids with Hypertension and Insulin Resistance among Rural Uyghur Adults in Far Western China , 2015, International journal of environmental research and public health.

[10]  M. McDermott.  Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. , 2015, Circulation research.

[11]  V. Aboyans,et al.  Epidemiology of peripheral artery disease. , 2015, Circulation research.

[12]  K. Kajiwara,et al.  A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus , 2015, Lipids in Health and Disease.

[13]  Jian-cheng Tu,et al.  Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction , 2014, BMC Cardiovascular Disorders.

[14]  D. Mozaffarian,et al.  Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study). , 2014, The American journal of cardiology.

[15]  D. Mozaffarian,et al.  Plasma Free Fatty Acids and Risk of Heart Failure: The Cardiovascular Health Study , 2013, Circulation. Heart failure.

[16]  Sarah Calhoun,et al.  Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008. , 2012, Journal of the American College of Cardiology.

[17]  I. D. de Boer,et al.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study , 2012, Vascular medicine.

[18]  S. Tiberti,et al.  Oxidative stress and endothelial dysfunction: say NO to cigarette smoking! , 2010, Current pharmaceutical design.

[19]  J. Kirwan,et al.  Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance. , 2010, The Journal of clinical endocrinology and metabolism.

[20]  A. Shulkes,et al.  Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations. , 2008, The American journal of clinical nutrition.

[21]  R. Langer,et al.  Ethnic-specific prevalence of peripheral arterial disease in the United States. , 2007, American journal of preventive medicine.

[22]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[23]  G. Bakris,et al.  Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance? , 2007, Journal of Human Hypertension.

[24]  W. März,et al.  Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. , 2006, The Journal of clinical endocrinology and metabolism.

[25]  R. Langer,et al.  Ethnicity and Peripheral Arterial Disease: The San Diego Population Study , 2005, Circulation.

[26]  J. Polak,et al.  Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. , 2005, Archives of internal medicine.

[27]  F. Kim,et al.  Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[29]  S. Shankar,et al.  FFAs: Do they play a role in vascular disease in the insulin resistance syndrome? , 2005, Current diabetes reports.

[30]  M. Jensen,et al.  Pioglitazone increases non-esterified fatty acid clearance in upper body obesity , 2005, Diabetologia.

[31]  Luigi Ferrucci,et al.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. , 2004, JAMA.

[32]  P. Iozzo,et al.  Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver , 2004, Diabetologia.

[33]  J. Morrow,et al.  DASH Diet Lowers Blood Pressure and Lipid-Induced Oxidative Stress in Obesity , 2003, Hypertension.

[34]  R. Kronmal,et al.  Multiple imputation of baseline data in the cardiovascular health study. , 2003, American journal of epidemiology.

[35]  M. Wong,et al.  Non-esterified fatty acid levels and physical inactivity: the relative importance of low habitual energy expenditure and cardio-respiratory fitness , 2002, British Journal of Nutrition.

[36]  J. Guralnik,et al.  The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study , 2002, Annals of Internal Medicine.

[37]  J. Morrow,et al.  Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster , 2002, Journal of hypertension.

[38]  B. Egan,et al.  The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. , 2001, American journal of hypertension.

[39]  B. Egan,et al.  Hemodynamic effects of lipids in humans. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  A. Baron,et al.  Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. , 2000, Diabetes.

[41]  B. Egan,et al.  Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. , 1998, Hypertension.

[42]  J. Guralnik,et al.  The Ankle Brachial Index Independently Predicts Walking Velocity and Walking Endurance in Peripheral Arterial Disease , 1998, Journal of the American Geriatrics Society.

[43]  B. Balkau,et al.  High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. , 1998, International journal of epidemiology.

[44]  A. Baron,et al.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.

[45]  A. Golay,et al.  Insulin action and non-esterified fatty acids , 1997, Proceedings of the Nutrition Society.

[46]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[47]  B. Egan,et al.  Obesity hypertension is related more to insulin's fatty acid than glucose action. , 1996, Hypertension.

[48]  B. Egan,et al.  Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. , 1995, Hypertension.

[49]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[50]  A. Vollmer,et al.  Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. , 1995, Hypertension.

[51]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[52]  J. Gardin,et al.  Assessment of cerebrovascular disease in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[53]  J. Hill,et al.  Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. , 1992, The American journal of physiology.

[54]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[55]  J. Bülow,et al.  Reversibility of the effects on local circulation of high lipid concentrations in blood. , 1990, Scandinavian journal of clinical and laboratory investigation.

[56]  A. Cayatte,et al.  Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. , 1990, The Journal of biological chemistry.

[57]  P. Björntorp,et al.  Plasma free fatty acid turnover rate in obesity. , 2009, Acta medica Scandinavica.

[58]  S. Bellet,et al.  Effect of Cigarette Smoking and Nicotine on Serum Free Fatty Acids: Based on a Study in the Human Subject and the Experimental Animal , 1961, Circulation research.

[59]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.